Jacqualyn A. Fouse, Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), bought 40,322 shares at $31.00 ($1.2M) on 2019-11-13, disclosed to the SEC on 2019-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AGIO | SELL | 2024-01-24 | $464K | — | Filing → |
| AGIO | SELL | 2024-01-09 | $386K | — | Filing → |
| AGIO | SELL | 2023-06-30 | $608K | — | Filing → |